Predictive Parameters of Febrile Neutropenia and Clinical Significance of G-CSF Receptor Signaling Pathway in the Development of Neutropenia during R-CHOP Chemotherapy with Prophylactic Pegfilgrastim in Patients with Diffuse Large B-Cell Lymphoma
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- KCISCIEScopus
- 저널 순위
- JCR Q2Scopus Q1KCI Q2
- 저널
- Cancer Research and Treatment54(4) · pp.1256 · 2022
- 피인용
- Web of Science 6Scopus 7KCI 1
- FWCI (Scopus)
- 0.31
- JCR IF
- JCR 2021 5.036
- ISSN
- 1598-2998
저자
- 김도영제1저자Pusan Natl Univ, Pusan Natl Univ Hosp, Biochem Res Inst, Dept Internal Med,Div Hematol Oncol,Sch Med, 179 Gudeok Ro, Busan 49241, South Korea
- 남제현Pusan Natl Univ, Dept Biol Sci, 2 Busatidaehak Ro 63Beon Gil, Busan 46241, South Korea
- 정주섭Pusan Natl Univ, Pusan Natl Univ Hosp, Biochem Res Inst, Dept Internal Med,Div Hematol Oncol,Sch Med, 179 Gudeok Ro, Busan 49241, South Korea
- 전별은Pusan Natl Univ, Dept Biol Sci, 2 Busatidaehak Ro 63Beon Gil, Busan 46241, South Korea
- Lee, Ji HyunDong A Univ Coll Med, Dept Internal Med, Busan, South Korea
- Jo, Jae-CheolUlsan Univ Hosp, Dept Internal Med, Div Hematol Oncol, Ulsan, South Korea
- 김상우교신저자Pusan Natl Univ, Dept Biol Sci, 2 Busatidaehak Ro 63Beon Gil, Busan 46241, South Korea
- 신호진교신저자Pusan Natl Univ, Pusan Natl Univ Hosp, Biochem Res Inst, Dept Internal Med,Div Hematol Oncol,Sch Med, 179 Gudeok Ro, Busan 49241, South Korea
초록
Purpose Pegfilgrastim is widely used to prevent chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) in patients with diffuse large B-cell lymphoma (DLBCL). We investigated the predictive factors affecting CIN and FN incidence in patients with DLBCL receiving rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy with pegfilgrastim and conducted experiments to find reason for the occurrence of CIN even when pegfilgrastim was used. Materials and Methods We reviewed the CIN and FN events of 200 patients with DLBCL. Based on these data, we investigate the association with predictive factor and the levels of granulocyte-colony stimulating factor (G-CSF) receptor signaling pathway markers (pSTAT3, pAKT, pERK1/2, pBAD, and CXCR4) in bone marrow (BM) samples isolated from patients with DLBCL. Results FN was significantly associated with stage III/IV (hazard ratio [HR], 12.74) and low serum albumin levels (HR, 3.87). Additionally, patients with FN had lower progression-free survival (PFS; 2-year PFS, 51.1 % vs. 74.0%) and overall survival (OS; 2-year OS, 58.2% vs. 85.0%) compared to those without FN. The occurrence of CIN was associated with overexpression of G-CSF receptor signaling pathway markers, and expression levels of these markers were upregulated in BM cells co-cultured with DLBCL cells. The rate of neutrophil apoptosis was also higher in neutrophils co-cultured with DLBCL cells and was further promoted by treatment with doxorubicin. Conclusion Our findings suggest that high DLBCL burden may alter the BM environment and G-CSF receptor signaling pathway, even in chemotherapy-naive state, which may increase CIN frequency during R-CHOP chemotherapy.
키워드
NeutropeniaG-CSF receptorChemotherapyPegfilgrastimDiffuse large B-cell lymphomaCOLONY-STIMULATING FACTORSINGLE-ADMINISTRATION PEGFILGRASTIMRISK-FACTORSDAILY FILGRASTIMRECEIVING CHOPDOSE INTENSITYDOUBLE-BLINDRITUXIMABIMPACTMULTICENTER
식별자
- Scopus EID
- 2-s2.0-85140144052
- WoS UID
- 000891831900030
- KCI
- ART002886602



로그인
연구물 목록으로